Tweet
<img alt="" height="1" width="1" />
Cephalon seals $615M acquisition | Philadelphia Inquirer | 04/09/2010
Philadelphia Inquirer
Drug company Cephalon Inc., of Frazer, on Friday said it has completed its acquisition of Swiss pharmaceutical firm Mepha, a deal Cephalon valued at $615 million. The price was above the $590 million value reported by Cephalon when it first announced ...
Cephalon finishes acquisition of drugmaker MephaBusinessWeek
Cephalon completes Mepha acquisition; GSK to keep Stiefel plant open;FierceBiotech
Cephalon completes purchase of generic drug company MephaPhiladelphia Business Journal
Drug Store News -CNNMoney.com (press release)
all 32 news articles »
More...